Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chris Viehbacher
Pharma
Biogen CEO plots turnaround after 'weak' 2023 performance
While Biogen’s financials are in rough shape now, the company’s CEO, Chris Viebacher, sees reason to be optimistic about the future.
Fraiser Kansteiner
Feb 13, 2024 11:28am
After 40% reduction in workforce, Sage will shift to smaller HQ
Jan 25, 2024 10:55am
Biogen kicks off 1,000 layoffs
Aug 18, 2023 10:43am
Biogen pays $7.3B to acquire Reata and newly approved Skyclarys
Jul 28, 2023 11:17am
Reduction of 1,000 jobs will cut Biogen's workforce by 11.5%
Jul 25, 2023 11:05am
Another year of booming pay for biopharma chief execs
Jun 27, 2023 8:35am